王飞虎
博士,长聘教轨副教授,博士生导师,上海市海外高层次人才。2016年博士毕业于上海交通大学和中国医药工业研究院,获医学博士学位。同年博士后获聘于约翰霍普金斯大学,先后师从Honggang Cui教授和Justin Hanes 教授。2021年通过绿色人才引进通道受聘于上海交通大学。主要研究方向包括智能药物递送系统、免疫治疗制剂、肿瘤精准治疗等。已在Nat. Biomed. Eng., Sci. Adv., PNAS, ACS Nano, Adv. Drug Delive. Rev., JACS, Angew. Chem., Biomaterials, J. Control. Release 等国际权威学术期刊上发表研究论文45篇。对于有良好临床转化潜力的研究成果已申请6项PCT 或中国专利。主持国家自然科学基金、上海市科学技术委员会基金等5项。担任ACS Nano, Adv. Funct. Mater., J. Immunother. Cancer, Nano Lett., J. Control. Release, Biomaterials等十余国际期刊审稿人。
2005.09-2009.07 理学学士, 西安交通大学
2009.09-2012.06 工学硕士, 山东大学
2012.09-2016.06 医学博士, 上海交通大学和中国医药工业研究院
2016.07-2021.05 博士后研究员,约翰霍普金斯大学
2021.06-至今 长聘教轨副教授,博士生导师,上海交通大学
新型药物递送系统
多肽-药物偶联物和超分子药物
免疫工程与免疫治疗
肿瘤个性化精准治疗
1. 国家自然科学基金委员会,青年科学基金项目, 2022.01-2024.12,在研,主持。
2. 中央本级重大增减支项目,重点攻关项目,2021.09-2023.12,在研,主持。
3. 上海市科学技术委员会,“科技创新行动计划”生物医药科技支撑专项,2022.04-2025.03,主持。
4. 上海交通大学,“交大之星”计划医工交叉研究基金青年项目, 2022.01-2024.12,主持。
5. 上海交通大学,“交大之星”计划医工交叉研究基金青年项目, 2022.01-2024.12,主持。
1. Qi Shang, Yabing Dong, Yun Su, Faith Leslie, Mingjiao Sun, Feihu Wang*, Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy, Advanced Drug Delivery Reviews, 2022, 185: 114308.
2. Feihu Wang*, Hao Su, Dongqing Xu, Maya K Monroe, Caleb F Anderson, Weijie Zhang, Richard Oh, Zongyuan Wang, Xuanrong Sun, Han Wang, Fengyi Wan, Honggang Cui*, Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer, Biomaterials, 2021, 279 :121182.
3. Feihu Wang#, Hao Su#, Dongqing Xu, Wenbing Dai, Weijie Zhang, Zongyuan Wang, Caleb F. Aderson, Mengzhen Zheng, Richard Oh, Fengyi Wan, Honggang Cui*, Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel, Nature Biomedical Engineering, 2020, 4: 1090-1101.
4. Feihu Wang#, Dongqing Xu#, Hao Su, Weijie Zhang, Xuanrong Sun, Maya K. Monroe, Rami W. Chakroun, Zongyuan Wang, Wenbing Dai, Richard Oh, Han Wang, Qin Fan, Fengyi Wan*, Honggang Cui*, Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy, Science Advances, 2020, 6(18): eaaz8985.
5. Feihu Wang, Hao Su, Ran Lin, Rami W. Chakroun, Maya K. Monroe, Zongyuan Wang, Michael Porter, Honggang Cui*, Supramolecular tubustecan hydrogel as chemotherapeutic carrier to improve tumor penetration and local treatment efficacy, ACS Nano, 2020, 14: 10083-10094.
6. Hao Su#, Feihu Wang#, Wei Ran, Weijie Zhang, Wenbing Dai, Han Wang, Caleb F. Anderson, Zongyuan Wang, Chao Zheng, Pengcheng Zhang, Yaping Li, Honggang Cui*, The role of critical micellization concentration in efficacy and toxicity of supramolecular polymers, Proceedings of the National Academy of Sciences, 2020, 117(9): 4518-4526 (Co-first author).
7. Feihu Wang, Qian Huang, Yun Wang, Leilei Shi, Yuanyuan Shen, Shengrong Guo*, NIR-light and GSH activated cytosolic p65-shRNA delivery for precise treatment of metastatic cancer, Journal of Controlled Release, 2018, 288: 126-135.
8. Feihu Wang, Qian Huang, Yun Wang, Wenjun Zhang, Ran Lin, Yanna Yu, Yuanyuan Shen, Honggang Cui*, Shengrong Guo*, Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis, Acta Biomaterialia, 2018, 77: 240-254.
所有文章列表:https://scholar.google.com/citations?user=WMsl0_kAAAAJ&hl=en
邮箱地址:fhwang21@sjtu.edu.cn
办公地址:国家转化医学大楼N310